$40 billion for Maternal, Newborn and Child Health
By Ian Anderson
1 December 2010
At the recent UN Summit on the Millennium Development Goals $US 40 billion was committed to be spent over the next five years to improve Maternal Newborn and Child Health (MNCH) in developing countries.
Large and high profile initiatives are nothing new, especially for the UN. And financial commitments often involve double counting, or fail to materialise in practice, or on time, or on genuinely concessional terms.
So what is this latest initiative and what makes it noteworthy?
The pledges are intended to support the newly formed Global Strategy For Women’s and Children’s Health which aims to save some 16 million lives of women and children in developing countries between now and 2015, avert 33 million unwanted pregnancies, and protect some 88 million children from stunting.
The initiative reflects a number of things:
- reducing maternal mortality (Millennium Development Goal 5) is the least likely of all of the MDGs to be achieved by 2015;
- affordable and proven interventions that reduce maternal, infant and child deaths have long been available;
- inadequate, inequitable, and inefficient public expenditure plays a key role in explaining poor health outcomes for poor women and their children; and
- well managed investments in maternal and child health can strengthen health systems more broadly, through better prevention, promotive, treatment and referral systems.
This isn’t new, but there are are three things that make this new initiative remarkable.
First, the commitments are increasingly strategic, specific, and verifiable. Bangladesh commits to doubling the percentage of births attended by a skilled health worker – from the current level of 24% – through training an additional 3000 midwives, and upgrading all 59 district hospitals. It also commits to halving the unmet need for family planning by 2015, along with several other initiatives. Cambodia will ensure that 95% of the poor are covered by health equity funds (so that health costs do not prevent a barrier to care, or a source of impoverishment) and availability of emergency obstetric care at district level, and increase the proportion of deliveries assisted by skilled birth attendants to 70%. Indonesia will ensure all deliveries will be performed by skilled birth attendants by 2015 etc..
Development partners have also made specific and important commitments: Australia will invest around $US 1.5 billion over the five years to 2015 on interventions evidence shows will improve maternal and child health outcomes; Japan will provide an additional $500 million for MNCH up to 2015 as part of a $US 5 billion Global Health Policy. The UK will double its annual support for MNCH. The UN and multilateral agencies also support the Global Strategy through various commitments with, for example, the World Bank expanding its results based programs by more than $US 600 million to scale up essential health and nutrition programs.
Private sector and civil society involvement
The second thing that makes the $US 40 billion commitments noteworthy is engagement of the private sector, and civil society.
The private sector’s specific, innovative, and tangible commitments include:
- GlaxoSmithKline commits to provide 200 million doses of deworming treatment for children; keep profit margins on drugs sold in low income countries to no more than 30% of the US profit margin; and to reinvest 20% of the profits made on these drugs in low income countries into infrastructure in those countries.
- Johnson and Johnson commits $US 200 million over the next 5 years, including provision of more than 15 million expectant mothers with free mobile phone messages on prenatal health, reminders of clinic appointments and calls from health mentors.
- Pfizer commits an estimated $US 200 million over the next 5 years, including through infant immunisation for pneumococcal disease.
- Merck commits an estimated $US 840 million over the next 5 years through their HIV prevention and treatment, childhood asthma programs and donation of Human Papilloma Virus vaccines.
18 philanthropies and 20 civil society organisations also made specific commitments. Illustrative and selected examples include:
- Bill and Melinda Gates Foundation which commits $US 1.5 billion over the next 5 years to improving MNCH;
- CARE which commits $US 1.8 billion over the next 5 years;
- Amnesty International which will advocate for equal and timely access to reproductive healthcare services for all women and girls; and
- Save the Children which commits $US 500 million per year for the next five years for MNCH.
(Further details on all these commitments are are available here.)
Regional follow up
The third aspect that makes this initiative noteworthy is that is that it is being followed up at regional levels including high profile sessions on what this means for Asia. This is important, because global achievement of the MDGs is impossible without further and sustained progress in Asia. Indeed, about half of all under five deaths occur in five countries, three of which – India, Pakistan and China – are in Asia. (Nigeria and Republic of Congo are the other two countries). Almost one fifth of all child deaths occur in India alone.
More than 1000 partners from 50 countries therefore participated in the From Pledges to Action and Accountability conference in New Delhi (13–14 November) to identify the policy and programming measures needed to be taken to implement these recent initiatives globally. Further details on the recent high profile conference in New Delhi are available from the Partnership for Maternal Newborn and Child Health (PMNCH) website.
The Partnership for Maternal, Newborn and Child Health promises to ‘invest, deliver and advance.’ And with tangible commitments from both developing and rich countries, active participation by the private sector and civil society, and a program of regional follow-up, this new initiative has the potential to make real progress.
Ian Anderson is a consultant and a Research Associate with the Development Policy Centre. He has recently completed almost 25 years at AusAID. Ian specialises in the economics and financing of the health-related MDGs.
About the author/s
Ian Anderson is an Associate at the Development Policy Centre. He has a PhD from the Crawford School of Public Policy, Australian National University, and over 25 years of experience at AusAID.